Source comparison
TB-500 Research Menopause Considerations: Comparison Table
Cardiovascular repair VEGF upregulation, endothelial progenitor cell migration, capillary density increase Compensates for estrogen withdrawal's impaired eNOS activity and reduced progenitor cell mobilization Preclinical: strong. Human: Phase I/II mixed cohort
This comparison does not assign a generated winner or score.
- Cardiovascular repair
- VEGF upregulation, endothelial progenitor cell migration, capillary density increase
- Compensates for estrogen withdrawal's impaired eNOS activity and reduced progenitor cell mobilization
- Preclinical: strong. Human: Phase I/II mixed cohorts only
- Mechanism aligns with postmenopausal vascular dysfunction, but no dedicated menopausal trials exist
- Musculoskeletal healing
- Collagen type I/III synthesis, MMP-2/9 upregulation, actin-mediated cell migration
- Addresses estrogen withdrawal's accelerated collagen degradation and tendon brittleness
- Preclinical: strong. Human: case reports and small observational series
- Relevant pathway, but evidence is extrapolated from younger athletic populations
- Immune modulation
- IL-6 and TNF-alpha reduction, regulatory T-cell preservation
- Targets postmenopausal 'inflammaging' and chronic low-grade inflammation
- Preclinical: moderate. Human: no specific menopausal cohorts
- Cytokine modulation is documented, but translation to menopause-specific inflammatory profiles is untested
- Bone vascularization
- Angiogenesis in bone tissue, microvascular density increase
- Supports bone remodeling in context of reduced osteoblast activity post-menopause
- Preclinical: emerging. Human: none
- Indirect mechanism (vascular supply to bone) is biologically sound but lacks clinical validation